Expert recommendations on booster immunization strategies of 2019-nCoV vaccines
10.3760/cma.j.issn.1674-2397.2022.03.003
- VernacularTitle:新型冠状病毒疫苗加强免疫策略的进展及专家建议
- Author:
Shuo SONG
1
;
Hongyang YI
;
Qian LI
;
Yang YANG
;
Jiayin SHEN
;
Jianqing XU
;
Hongzhou LU
Author Information
1. 深圳市第三人民医院感染科 518112
- Keywords:
2019-nCoV vaccine;
Sequential booster immunization;
Novel vaccine;
Expert recommendations
- From:
Chinese Journal of Clinical Infectious Diseases
2022;15(3):176-184
- CountryChina
- Language:Chinese
-
Abstract:
Since the end of 2019, the COVID-19 caused by 2019-nCoV has emerged and the pandemic ravaged the world, which seriously threatens global public health security and economic development. 2019-nCoV vaccine is an effective weapon to combat the viral infection, however, studies have shown that vaccine-induced immune protection decreases over time, coupled with some novel and immune escape variants continual emerging. Therefore, it is urgent to complete booster immunization to improve protection. At present, 2019-nCoV vaccines based on a variety of technical platforms have been approved and available in China. Therefore, we developed this sequential vaccination strategy guide to provide documentation guidance for the prevention and control of the epidemic caused by 2019-nCoV and its variant strains.
